Article
San Francisco -- While biological byproducts such as growth factors have a potential role in skin rejuvenation, there is not yet sufficient evidence to measure their true efficacy, according to recent research.
Polynucleotide Therapy Shows Promise in Scar and Burn Management
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
Jeff Stark, MD: Insights on the Approval of Bimekizumab for HS
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Maximizing the 2-Fold Benefits of Your Charitable Donations
Conference Recap: 2024 Society of Dermatology Physician Associates Fall Dermatology Conference